Breaking News

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	Jana Partners buys TreeHouse Foods, exits Callaway in Q4 » 16:46 02/16/21 02/16 16:46 02/16/21 16:46 LH LabCorp $236.18 / -1.835 (-0.77%) , THS TreeHouse $48.91 / -0.48 (-0.97%) , TGNA Tegna $17.59 / -0.095 (-0.54%) , GRA W.R. Grace $59.83 / -0.28 (-0.47%) , ELY Callaway Golf $28.36 / -1.56 (-5.21%) , BCO Brink's $73.39 / +0.17 (+0.23%) , PRSP Perspecta $29.19 / +0.155 (+0.53%) , EHC Encompass Health $80.46 / -1.765 (-2.15%) , SPY SPDR S&P 500 ETF Trust $392.34 / -0.36 (-0.09%) , BLMN Bloomin' Brands $22.66 / -0.125 (-0.55%) , NEWR New Relic $63.48 / -1.955 (-2.99%) , CAG Conagra Brands $33.90 / -0.67 (-1.94%) Jana Partners disclosed… Jana Partners disclosed in an SEC filing its holdings as of December 31, 2020. Jana's four new buys during the fourth quarter included, by size of position, LabCorp (LH), TreeHouse Foods (THS), Tegna (TGNA), and W.R. Grace (GRA). The fund exited three positions during the quarter, including by size of previous position Callaway Golf (ELY) and Brink's Company (BCO). Jana increased its stake in two holdings, including by size of previous position Perspecta (PRSP) and Encompass Health (EHC). The fund decreased its stake in three holdings, including by size of previous position SPDR S&P 500 ETF Trust (SPY), Bloomin' Brands (BLMN), and New Relic (NEWR). Jana's top holdings as of December 31, in order of size, were Conagra (CAG), Perspecta, Encompass Health, LabCorp, and SPDR S&P 500 ETF Trust. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options Technical Analysis THS TGNA SPY PRSP NEWR LH GRA ELY EHC CAG BCO THS TreeHouse $48.91 / -0.48 (-0.97%) 02/10/21 TreeHouse says board will review Jana's board nominees 02/10/21 TreeHouse rises 17.5% 02/10/21 TreeHouse rises 15.6% 02/10/21 TreeHouse jumps after Jana reports stake, says sale may be discussed TGNA Tegna $17.59 / -0.095 (-0.54%) 02/10/21 Entercom announces content agreement with Tegna podcast network 01/27/21 Tegna acquires Locked On Podcast Network 01/21/21 Tegna to evaluate Standard General board nominees 01/07/21 Tegna, FreeWheel announce new multi-year deal SPY SPDR S&P 500 ETF Trust $392.34 / -0.36 (-0.09%) 02/16/21 Starboard Value buys ON Semi, cuts Advance Auto stake in Q4 02/01/21 Robinhood raises $3.4B to continue investing in customer growth 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil PRSP Perspecta $29.19 / +0.155 (+0.53%) 01/27/21 Perspecta trading resumes 01/27/21 Veritas Capital to acquire Perspecta in all-cash transaction valued at $7.1B 01/27/21 Veritas Capital to acquire Perspecta in all-cash transaction valued at $7.1B 01/27/21 Perspecta trading halted, news pending NEWR New Relic $63.48 / -1.955 (-2.99%) 02/05/21 New Relic falls -16.3% 02/05/21 New Relic falls -17.4% 02/05/21 New Relic falls -19.4% 01/12/21 New Relic announces integration with Snowflake LH LabCorp $236.18 / -1.835 (-0.77%) 02/11/21 LabCorp sees FY21 free cash flow $1.7B-$1.9B 01/19/21 LabCorp appoints Dr. Deborah Ann Sesok-Pizzini as Chief Medical Officer 01/07/21 LabCorp awarded CDC contract to study COVID-19 variants 12/21/20 Walgreens Boots Alliance, LabCorp: Pixel by Labcorp COVID-19 kit now available GRA W.R. Grace $59.83 / -0.28 (-0.47%) 02/09/21 W.R. Grace targeting long-term sales growth of mid-single digits 02/09/21 W.R. Grace raises dividend to 33c 01/15/21 W R Grace and Co trading resumes 01/15/21 W.R. Grace responds to 40 North, says 'willing to discuss a sale' ELY Callaway Golf $28.36 / -1.56 (-5.21%) 02/10/21 Callaway Golf drops 8% to $28.91 after Q4 earnings misses estimates 01/04/21 Callaway Golf says Jon Rahm has joined its Tour professional staff 11/16/20 Jana Partners buys Encompass Health, exits Hillebrand in Q3 11/09/20 Callaway Golf CEO says 'Q3's trends have thus far continued into Q4' EHC Encompass Health $80.46 / -1.765 (-2.15%) 02/08/21 Encompass Health to build 40-bed inpatient rehabilitation hospital in Oklahoma 01/26/21 Encompass Health: 'No decision has been made' on home health and hospice unit 01/06/21 Encompass Health, UnityPoint Health to build rehabilitation hospital in Illinois 12/09/20 Encompass Health exploring alternatives for Home Health and Hospice business CAG Conagra Brands $33.90 / -0.67 (-1.94%) 01/25/21 Post Holdings completes acquisition of Conagra Brands' Peter Pan brand 01/07/21 Conagra Brands reports gross debt reduction of $2.3B since Pinnacle Foods close 01/07/21 Conagra Brands CEO: Q2 results 'reflect strong performance across the business' 12/28/20 Conagra Brands issues SASB disclosure for 2020 BCO Brink's $73.39 / +0.17 (+0.23%) 10/29/20 Brink's sees FY21 adjusted EBITDA $615M-$805M 08/26/20 Brink's announces $50M acclerated share repurchase LH THS TGNA GRA ELY BCO PRSP EHC SPY BLMN NEWR CAG LH LabCorp $236.18 / -1.835 (-0.77%) 02/12/21 JPMorgan LabCorp price target raised to $279 from $261 at JPMorgan 02/12/21 Mizuho LabCorp price target raised to $267 from $242 at Mizuho 02/12/21 Citi LabCorp price target raised to $278 from $257 at Citi 01/29/21 Citi LabCorp price target raised to $257 from $249 at Citi THS TreeHouse $48.91 / -0.48 (-0.97%) 02/12/21 Truist TreeHouse downgraded to Hold from Buy at Truist 02/12/21 Truist TreeHouse downgraded to Hold from Buy at Truist 02/12/21 BofA TreeHouse downgraded to Neutral from Buy at BofA 02/12/21 BofA TreeHouse downgraded to Neutral from Buy at BofA TGNA Tegna $17.59 / -0.095 (-0.54%) 01/08/21 Barrington Tegna price target raised to $20 from $18 at Barrington 12/16/20 Huber Research Tegna downgraded to Underweight from Overweight at Huber Research 08/11/20 Wells Fargo Tegna upgraded to Overweight from Equal Weight at Wells Fargo 04/16/20 Wells Fargo Tegna price target lowered to $11 from $18 at Wells Fargo GRA W.R. Grace $59.83 / -0.28 (-0.47%) 02/10/21 Credit Suisse W.R. Grace price target raised to $69 from $57 at Credit Suisse 01/19/21 CL King W.R. Grace price target raised to $70 from $67 at CL King 01/19/21 Monness Crespi W.R. Grace expresses 'openness' to work with 40 North, says Monness Crespi 01/15/21 Wells Fargo W.R. Grace response to 40 North suggests higher odds of deal, says Wells Fargo ELY Callaway Golf $28.36 / -1.56 (-5.21%) 02/16/21 Cowen Callaway Golf valuation looks rich, Cowen downgrades to Market Perform 02/16/21 Cowen Callaway Golf downgraded to Market Perform from Outperform at Cowen 02/11/21 B. Riley Securities Callaway Golf price target raised to $35 from $33 at B. Riley Securities 02/08/21 Jefferies Jefferies says buy Callaway Golf into Q4 EPS report BCO Brink's $73.39 / +0.17 (+0.23%) 01/15/21 Truist Brink's price target raised to $96 from $90 at Truist 12/15/20 Truist Brink's price target raised to $90 from $80 at Truist 05/18/20 Standpoint Research Brink's upgraded to Buy from Hold at Standpoint Research 05/07/20 Imperial Capital Brink's price target lowered to $80 from $98 at Imperial Capital PRSP Perspecta $29.19 / +0.155 (+0.53%) 02/08/21 Stifel Stifel cuts Perspecta rating to Hold as results unlikely to attract new bidders 02/08/21 Stifel Perspecta downgraded to Hold from Buy at Stifel 01/27/21 Stifel CACI 'very likely' to bid on Perspecta as well, says Stifel 06/12/20 William Blair William Blair sees near-term takeover of Perspecta as unlikely despite Jana news EHC Encompass Health $80.46 / -1.765 (-2.15%) 01/28/21 Credit Suisse Encompass Health price target lowered to $92 from $97 at Credit Suisse 01/28/21 Deutsche Bank Encompass Health price target raised to $87 from $70 at Deutsche Bank 01/15/21 UBS Encompass Health price target raised to $106 from $85 at UBS 12/18/20 Mizuho Encompass Health price target raised to $90 from $87 at Mizuho SPY SPDR S&P 500 ETF Trust $392.34 / -0.36 (-0.09%) 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 BLMN Bloomin' Brands $22.66 / -0.125 (-0.55%) 01/25/21 JPMorgan Bloomin' Brands price target raised to $25 from $22 at JPMorgan 01/22/21 Deutsche Bank Bloomin' Brands price target raised to $26 from $22 at Deutsche Bank 01/19/21 Goldman Sachs Bloomin' Brands initiated with a Sell at Goldman Sachs 12/14/20 JPMorgan Bloomin' Brands price target raised to $22 from $20 at JPMorgan NEWR New Relic $63.48 / -1.955 (-2.99%) 02/05/21 Fly Intel: Top five analyst downgrades 02/05/21 Raymond James New Relic downgraded to Market Perform from Strong Buy at Raymond James 02/05/21 Loop Capital New Relic price target raised to $70 from $60 at Loop Capital 02/05/21 BMO Capital New Relic price target raised to $71 from $64 at BMO Capital CAG Conagra Brands $33.90 / -0.67 (-1.94%) 01/12/21 Jefferies Conagra Brands price target lowered to $40 from $41 at Jefferies 01/08/21 Credit Suisse Conagra Brands price target lowered to $33 from $34 at Credit Suisse 01/05/21 Credit Suisse Conagra Brands downgraded to Underperform from Neutral at Credit Suisse 09/29/20 RBC Capital Conagra Brands product line benefits from current environment, says RBC Capital THS TGNA PRSP NEWR LH GRA ELY EHC CAG BLMN BCO THS TreeHouse $48.91 / -0.48 (-0.97%) 02/11/21 TreeHouse sees 2021 adjusted EPS $2.80-$3.20, consensus $3.02 02/11/21 TreeHouse reports Q4 adjusted EPS $1.07, consensus $1.06 02/10/21 Notable companies reporting before tomorrow's open TGNA Tegna $17.59 / -0.095 (-0.54%) 01/06/21 Tegna sees FY20 revenue $2.93B-$2.94B, consensus $2.91B 01/06/21 Tegna reports preliminary Q4 revenue $932M-$937M, consensus $904.12M 11/09/20 Tegna reports Q3 EPS 59c, consensus 49c 10/15/20 Tegna sees Q3 revenue up 34% to $738M, consensus 677.74M PRSP Perspecta $29.19 / +0.155 (+0.53%) 02/05/21 Perspecta reports Q3 adjusted EPS 56c, consensus 52c 11/10/20 Perspecta raises FY21 adj. EPS view to $2.03-$2.11 from $1.90-$2.03 11/10/20 Perspecta reports Q2 adjusted EPS 53c, consensus 50c NEWR New Relic $63.48 / -1.955 (-2.99%) 02/04/21 New Relic sees Q4 EPS (45c)-(49c), consensus (12c) 02/04/21 New Relic reports Q3 EPS (14c), consensus (14c) 11/05/20 New Relic sees Q3 adjusted EPS (17c)-(13c), consensus (2c) 11/05/20 New Relic reports Q2 EPS (7c), consensus 1c LH LabCorp $236.18 / -1.835 (-0.77%) 02/11/21 LabCorp sees FY21 adjusted EPS $19.00-$23.00, consensus $20.14 02/11/21 LabCorp reports Q4 adjusted EPS $10.56, consensus $8.11 10/27/20 LabCorp continues to not provide 2020 guidance 10/27/20 LabCorp reports Q3 adjusted EPS $8.41, consensus $5.25 GRA W.R. Grace $59.83 / -0.28 (-0.47%) 02/09/21 W.R. Grace sees Q1 adjusted EPS 77c-80c, consensus 83c 02/09/21 W.R. Grace sees FY21 adjusted EPS $3.63-$3.93, consensus $3.84 02/09/21 W.R. Grace reports Q4 adjusted EPS 88c, consensus 86c 10/28/20 W.R. Grace sees Q4 adjusted EPS 84c-88c, consensus 94c ELY Callaway Golf $28.36 / -1.56 (-5.21%) 02/10/21 Callaway Golf reports Q4 adjusted EPS (33c), consensus (19c) 02/10/21 Notable companies reporting after market close 11/09/20 Callaway Golf not providing Q4 guidance 11/09/20 Callaway Golf reports Q3 adjusted EPS 60c, consensus 38c EHC Encompass Health $80.46 / -1.765 (-2.15%) 01/26/21 Encompass Health provides 2020-2025 growth targets 01/26/21 Encompass Health sees FY21 adjusted EPS $3.31-$3.53, consensus $3.83 01/26/21 Encompass Health reports Q4 adjusted EPS 93c, consensus 85c 10/28/20 Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c CAG Conagra Brands $33.90 / -0.67 (-1.94%) 01/07/21 Conagra Brands says sale of Peter Pan unit to reduce annual sales by ~$110M 01/07/21 Conagra Brands backs FY22 adjusted EPS view $2.66-$2.76 01/07/21 Conagra Brands sees Q3 adjusted EPS 56c-60c, consensus 56c 01/07/21 Conagra Brands reports Q2 adjusted EPS 81c, consensus 73c BLMN Bloomin' Brands $22.66 / -0.125 (-0.55%) 10/23/20 Bloomin' Brands reports Q3 adj. EPS (12c), consensus (35c) 10/22/20 Notable companies reporting before tomorrow's open BCO Brink's $73.39 / +0.17 (+0.23%) 01/21/21 Brink's expects Q4 revenue of approx. $1.02B, consensus $981.99M 10/29/20 Brink's sees FY20 adjusted EPS $2.90-$3.10, consensus $2.30 10/29/20 Brink's reports Q3 adjusted EPS 86c, consensus 46c THS TGNA SPY PRSP NEWR LH ELY EHC CAG THS TreeHouse $48.91 / -0.48 (-0.97%) 02/10/21 Jana pushing TreeHouse to explore potential sale, Bloomberg reports TGNA Tegna $17.59 / -0.095 (-0.54%) 10/02/20 Supreme Court to hear FCC push to ease media ownership rules, Reuters reports SPY SPDR S&P 500 ETF Trust $392.34 / -0.36 (-0.09%) 02/11/21 White House secures deals for additional 200M COVID-19 vaccine doses, CNBC says 02/10/21 Germany extending virus lockdown until March 7, AP reports 02/08/21 Gove says Britain, EU need reset after Northern Ireland threat, Reuters says 02/03/21 Biden indicates openness to sending direct checks to smaller group, WSJ says PRSP Perspecta $29.19 / +0.155 (+0.53%) 12/10/20 Perspecta working with Goldman to weigh options, Dealreporter says 11/09/20 Perspecta said to weigh strategic options, Bloomberg says NEWR New Relic $63.48 / -1.955 (-2.99%) 08/20/20 New Relic 'worth keeping an eye on' after board changes, Dealreporter says LH LabCorp $236.18 / -1.835 (-0.77%) 01/12/21 LabCorp CEO: COVID vaccine recipients don't need antibody test after, CNBC says 10/10/20 LabCorp 'now on a roll' after being tested by COVID, Barron's says ELY Callaway Golf $28.36 / -1.56 (-5.21%) 11/04/20 Callaway 'could be even more vulnerable' to activist, Dealreporter says 10/27/20 Callaway Golf close to deal to buy rest of Topgolf, WSJ reports EHC Encompass Health $80.46 / -1.765 (-2.15%) 01/29/21 Encompass Health activist Jana not 'appeased' by Q4 earnings, The Deal says CAG Conagra Brands $33.90 / -0.67 (-1.94%) 02/16/21 Kraft Heinz, Conagra Brands could raise cost of certain goods, Reuters reports THS TGNA PRSP NEWR LH GRA ELY CAG BLMN THS TreeHouse $48.91 / -0.48 (-0.97%) 02/12/21 Initiation of 'disrupter' Inovio among today's top calls on Wall Street TGNA Tegna $17.59 / -0.095 (-0.54%) 10/15/20 Fly Intel: Pre-market Movers PRSP Perspecta $29.19 / +0.155 (+0.53%) 01/27/21 Fly Intel: Wall Street's top stories for Wednesday 01/27/21 Fly Intel: Pre-market Movers NEWR New Relic $63.48 / -1.955 (-2.99%) 02/05/21 Peloton downgrade among today's top calls on Wall Street 02/04/21 Fly Intel: After-Hours Movers 11/24/20 Target upgrade, Microsoft initiation among today's top calls on Wall Street 11/05/20 Fly Intel: After-Hours Movers LH LabCorp $236.18 / -1.835 (-0.77%) 08/27/20 Abbott Labs jumps after securing FDA approval for $5 COVID-19 test GRA W.R. Grace $59.83 / -0.28 (-0.47%) 11/09/20 Fly Intel: Wall Street's top stories for Monday ELY Callaway Golf $28.36 / -1.56 (-5.21%) 02/11/21 Fly Intel: Pre-market Movers 02/10/21 Fly Intel: After-Hours Movers 10/28/20 Fly Intel: Wall Street's top stories for Wednesday 10/28/20 Fly Intel: Wall Street's top stories at midday CAG Conagra Brands $33.90 / -0.67 (-1.94%) 01/07/21 Fly Intel: Pre-market Movers BLMN Bloomin' Brands $22.66 / -0.125 (-0.55%) 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/23/20 Fly Intel: Pre-market Movers 09/01/20 Qualcomm, Zoom Video upgrades among today's top calls on Wall Street 03/30/21 Benchmark Virtual NAB Conference 02/18/21 Bloomin' Brands - BLMN 02/23/21 Brink's - BCO 03/01/21 Tegna - TGNA TGNA SPY LH ELY BLMN TGNA Tegna $17.59 / -0.095 (-0.54%) 01/21/21 Early notable gainers among liquid option names on January 21st 10/15/20 Early notable gainers among liquid option names on October 15th SPY SPDR S&P 500 ETF Trust $392.34 / -0.36 (-0.09%) 11/09/20 Options markets on track for record option volume LH LabCorp $236.18 / -1.835 (-0.77%) 10/27/20 Early notable gainers among liquid option names on October 27th 10/16/20 Early notable gainers among liquid option names on October 16th ELY Callaway Golf $28.36 / -1.56 (-5.21%) 11/11/20 Unusually active option classes on open November 11th 10/27/20 Callaway Golf call volume above normal and directionally bullish 10/26/20 Callaway Golf call volume above normal and directionally bullish 10/07/20 Unusual call flow in option market yesterday BLMN Bloomin' Brands $22.66 / -0.125 (-0.55%) 12/14/20 Unusual call flow in option market yesterday 12/11/20 Call calendar and put sale pop up in Bloomin' Brands SPY SPY SPDR S&P 500 ETF Trust $392.34 / -0.36 (-0.09%) 02/12/21 On The Fly: Weekly technical notes for S&P 500 02/12/21 On The Fly: ETF fund flow highlights 02/12/21 SPDR S&P 500 ETF Trust: Pivot points 02/11/21 SPDR S&P 500 ETF Trust: Pivot points
Hot Stocks	Encompass Health to build 40-bed inpatient rehabilitation hospital in Oklahoma » 07:30 02/08/21 02/08 07:30 02/08/21 07:30 EHC Encompass Health $82.21 / -1.07 (-1.28%) Encompass Health and… Encompass Health and Ascension St. John announced their plans to construct a 40-bed inpatient rehabilitation hospital on East 86th Street North in Owasso, Oklahoma, a northern suburb of Tulsa, Oklahoma. The future hospital is the joint venture's second location. Complementing local acute care services like those provided by Ascension St. John Owasso, the future hospital will offer physical, occupational and speech therapies, and 24-hour nursing care, to restore functional ability and quality of life. The hospital will feature all private patient rooms, a spacious therapy gym with advanced rehabilitation technologies and activities of daily living suite, cafeteria, dining room, pharmacy and therapy courtyard. ShowHide Related Items >><< Company News Street Research Earnings Periodicals EHC Encompass Health $82.21 / -1.07 (-1.28%) 01/26/21 Encompass Health: 'No decision has been made' on home health and hospice unit 01/06/21 Encompass Health, UnityPoint Health to build rehabilitation hospital in Illinois 12/09/20 Encompass Health exploring alternatives for Home Health and Hospice business 11/16/20 Jana Partners buys Encompass Health, exits Hillebrand in Q3 EHC Encompass Health $82.21 / -1.07 (-1.28%) 01/28/21 Credit Suisse Encompass Health price target lowered to $92 from $97 at Credit Suisse 01/28/21 Deutsche Bank Encompass Health price target raised to $87 from $70 at Deutsche Bank 01/15/21 UBS Encompass Health price target raised to $106 from $85 at UBS 12/18/20 Mizuho Encompass Health price target raised to $90 from $87 at Mizuho EHC Encompass Health $82.21 / -1.07 (-1.28%) 01/26/21 Encompass Health provides 2020-2025 growth targets 01/26/21 Encompass Health sees FY21 adjusted EPS $3.31-$3.53, consensus $3.83 01/26/21 Encompass Health reports Q4 adjusted EPS 93c, consensus 85c 10/28/20 Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c EHC Encompass Health $82.21 / -1.07 (-1.28%) 01/29/21 Encompass Health activist Jana not 'appeased' by Q4 earnings, The Deal says

Over a month ago
Periodicals	Encompass Health activist Jana not 'appeased' by Q4 earnings, The Deal says » 14:48 01/29/21 01/29 14:48 01/29/21 14:48 EHC Encompass Health $79.70 / -0.86 (-1.07%) While Encompass Health… While Encompass Health reported Q4 earnings that beat analyst consensus estimates, the "results and newly issued guidance haven't appeased activist Jana Partners," which previously revealed in November that it held a 1.8% stake in the company, reported The Deal, contacts tell The Fly. "Jana is engaging with the Birmingham, Ala.-based company behind the scenes," The Deal added, according to contacts. ShowHide Related Items >><< Company News Street Research Earnings EHC Encompass Health $79.70 / -0.86 (-1.07%) 01/26/21 Encompass Health: 'No decision has been made' on home health and hospice unit 01/06/21 Encompass Health, UnityPoint Health to build rehabilitation hospital in Illinois 12/09/20 Encompass Health exploring alternatives for Home Health and Hospice business 11/16/20 Jana Partners buys Encompass Health, exits Hillebrand in Q3 EHC Encompass Health $79.70 / -0.86 (-1.07%) 01/28/21 Credit Suisse Encompass Health price target lowered to $92 from $97 at Credit Suisse 01/28/21 Deutsche Bank Encompass Health price target raised to $87 from $70 at Deutsche Bank 01/15/21 UBS Encompass Health price target raised to $106 from $85 at UBS 12/18/20 Mizuho Encompass Health price target raised to $90 from $87 at Mizuho EHC Encompass Health $79.70 / -0.86 (-1.07%) 01/26/21 Encompass Health provides 2020-2025 growth targets 01/26/21 Encompass Health sees FY21 adjusted EPS $3.31-$3.53, consensus $3.83 01/26/21 Encompass Health reports Q4 adjusted EPS 93c, consensus 85c 10/28/20 Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c
Recommendations	Encompass Health price target lowered to $92 from $97 at Credit Suisse » 08:43 01/28/21 01/28 08:43 01/28/21 08:43 EHC Encompass Health $82.38 / -3.48 (-4.05%) Credit Suisse analyst… Credit Suisse analyst A.J. Rice lowered the firm's price target on Encompass Health to $92 from $97 and keeps an Outperform rating on the shares. The analyst believes the long-term outlook remains intact, with pandemic headwinds viewed as transitory. ShowHide Related Items >><< Company News Street Research Earnings EHC Encompass Health $82.38 / -3.48 (-4.05%) 01/26/21 Encompass Health: 'No decision has been made' on home health and hospice unit 01/06/21 Encompass Health, UnityPoint Health to build rehabilitation hospital in Illinois 12/09/20 Encompass Health exploring alternatives for Home Health and Hospice business 11/16/20 Jana Partners buys Encompass Health, exits Hillebrand in Q3 EHC Encompass Health $82.38 / -3.48 (-4.05%) 01/28/21 Deutsche Bank Encompass Health price target raised to $87 from $70 at Deutsche Bank 01/15/21 UBS Encompass Health price target raised to $106 from $85 at UBS 12/18/20 Mizuho Encompass Health price target raised to $90 from $87 at Mizuho 11/30/20 Raymond James Encompass Health price target raised to $90 from $78 at Raymond James EHC Encompass Health $82.38 / -3.48 (-4.05%) 01/26/21 Encompass Health provides 2020-2025 growth targets 01/26/21 Encompass Health sees FY21 adjusted EPS $3.31-$3.53, consensus $3.83 01/26/21 Encompass Health reports Q4 adjusted EPS 93c, consensus 85c 10/28/20 Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c
Recommendations	Encompass Health price target raised to $87 from $70 at Deutsche Bank » 07:32 01/28/21 01/28 07:32 01/28/21 07:32 EHC Encompass Health $82.38 / -3.48 (-4.05%) Deutsche Bank analyst… Deutsche Bank analyst Pito Chickering raised the firm's price target on Encompass Health to $87 from $70 and keeps a Hold rating on the shares. The shares traded down yesterday as investors remained wary of a softer 2021 EBITDA outlook and a lower base on reinstated long-term guidance, Chickering tells investors in a research note. The analyst, however, believes the long-term growth thesis is intact. ShowHide Related Items >><< Company News Street Research Earnings EHC Encompass Health $82.38 / -3.48 (-4.05%) 01/26/21 Encompass Health: 'No decision has been made' on home health and hospice unit 01/06/21 Encompass Health, UnityPoint Health to build rehabilitation hospital in Illinois 12/09/20 Encompass Health exploring alternatives for Home Health and Hospice business 11/16/20 Jana Partners buys Encompass Health, exits Hillebrand in Q3 EHC Encompass Health $82.38 / -3.48 (-4.05%) 01/15/21 UBS Encompass Health price target raised to $106 from $85 at UBS 12/18/20 Mizuho Encompass Health price target raised to $90 from $87 at Mizuho 11/30/20 Raymond James Encompass Health price target raised to $90 from $78 at Raymond James 11/23/20 Barclays Encompass Health upgraded to Overweight from Equal Weight at Barclays EHC Encompass Health $82.38 / -3.48 (-4.05%) 01/26/21 Encompass Health provides 2020-2025 growth targets 01/26/21 Encompass Health sees FY21 adjusted EPS $3.31-$3.53, consensus $3.83 01/26/21 Encompass Health reports Q4 adjusted EPS 93c, consensus 85c 10/28/20 Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c

Hot Stocks	Encompass Health: 'No decision has been made' on home health and hospice unit » 16:28 01/26/21 01/26 16:28 01/26/21 16:28 EHC Encompass Health $85.86 / +0.18 (+0.21%) On December 9, 2020, the… On December 9, 2020, the company announced it is exploring strategic alternatives for its home health and hospice business. The review is ongoing, and no decision has been made. Accordingly, the company's 2021 guidance and longer term growth targets assume the continuation of the current structure of the business. The guidance and growth targets may change depending on the ultimate outcome of the review. Base year 2020 adjusted free cash flow benefited from a temporary payroll tax holiday. Exclusive of this item, the adjusted free cash flow CAGR target would be 8%-10%. ShowHide Related Items >><< Company News Street Research Earnings Events EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/06/21 Encompass Health, UnityPoint Health to build rehabilitation hospital in Illinois 12/09/20 Encompass Health exploring alternatives for Home Health and Hospice business 11/16/20 Jana Partners buys Encompass Health, exits Hillebrand in Q3 11/10/20 Encompass receives certificate to build rehabilitation hospital in Illinois EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/15/21 UBS Encompass Health price target raised to $106 from $85 at UBS 12/18/20 Mizuho Encompass Health price target raised to $90 from $87 at Mizuho 11/30/20 Raymond James Encompass Health price target raised to $90 from $78 at Raymond James 11/23/20 Barclays Encompass Health upgraded to Overweight from Equal Weight at Barclays EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/26/21 Encompass Health provides 2020-2025 growth targets 01/26/21 Encompass Health sees FY21 adjusted EPS $3.31-$3.53, consensus $3.83 01/26/21 Encompass Health reports Q4 adjusted EPS 93c, consensus 85c 10/28/20 Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c 01/27/21 Encompass Health - EHC
Earnings	Encompass Health provides 2020-2025 growth targets » 16:25 01/26/21 01/26 16:25 01/26/21 16:25 EHC Encompass Health $85.86 / +0.18 (+0.21%) 2020-2025 growth targets:… 2020-2025 growth targets: Net operating revenues 8%-10% CAGR; Adjusted EBITDA 8%-10% CAGR; Adjusted free cash flow 5%-7% CAGR. ShowHide Related Items >><< Company News Street Research Earnings Events EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/06/21 Encompass Health, UnityPoint Health to build rehabilitation hospital in Illinois 12/09/20 Encompass Health exploring alternatives for Home Health and Hospice business 11/16/20 Jana Partners buys Encompass Health, exits Hillebrand in Q3 11/10/20 Encompass receives certificate to build rehabilitation hospital in Illinois EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/15/21 UBS Encompass Health price target raised to $106 from $85 at UBS 12/18/20 Mizuho Encompass Health price target raised to $90 from $87 at Mizuho 11/30/20 Raymond James Encompass Health price target raised to $90 from $78 at Raymond James 11/23/20 Barclays Encompass Health upgraded to Overweight from Equal Weight at Barclays EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/26/21 Encompass Health sees FY21 adjusted EPS $3.31-$3.53, consensus $3.83 01/26/21 Encompass Health reports Q4 adjusted EPS 93c, consensus 85c 10/28/20 Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c 10/28/20 Encompass Health reports Q3 adjusted EPS 78c, consensus 78c 01/27/21 Encompass Health - EHC
Earnings	Encompass Health sees FY21 adjusted EPS $3.31-$3.53, consensus $3.83 » 16:23 01/26/21 01/26 16:23 01/26/21 16:23 EHC Encompass Health $85.86 / +0.18 (+0.21%) Sees FY21 revenue… Sees FY21 revenue $5B-$5.17B, consensus $5.06B. Sees FY21 adjusted EBITDA $925M-$955M. ShowHide Related Items >><< Company News Street Research Earnings Events EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/06/21 Encompass Health, UnityPoint Health to build rehabilitation hospital in Illinois 12/09/20 Encompass Health exploring alternatives for Home Health and Hospice business 11/16/20 Jana Partners buys Encompass Health, exits Hillebrand in Q3 11/10/20 Encompass receives certificate to build rehabilitation hospital in Illinois EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/15/21 UBS Encompass Health price target raised to $106 from $85 at UBS 12/18/20 Mizuho Encompass Health price target raised to $90 from $87 at Mizuho 11/30/20 Raymond James Encompass Health price target raised to $90 from $78 at Raymond James 11/23/20 Barclays Encompass Health upgraded to Overweight from Equal Weight at Barclays EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/26/21 Encompass Health reports Q4 adjusted EPS 93c, consensus 85c 10/28/20 Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c 10/28/20 Encompass Health reports Q3 adjusted EPS 78c, consensus 78c 07/27/20 Encompass Health reports Q2 adjusted EPS 31c, consensus 42c 01/27/21 Encompass Health - EHC
Earnings	Encompass Health reports Q4 adjusted EPS 93c, consensus 85c » 16:21 01/26/21 01/26 16:21 01/26/21 16:21 EHC Encompass Health $85.86 / +0.18 (+0.21%) Reports Q4 revenue… Reports Q4 revenue $1.21B, consensus $1.21B. ShowHide Related Items >><< Company News Street Research Earnings Events EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/06/21 Encompass Health, UnityPoint Health to build rehabilitation hospital in Illinois 12/09/20 Encompass Health exploring alternatives for Home Health and Hospice business 11/16/20 Jana Partners buys Encompass Health, exits Hillebrand in Q3 11/10/20 Encompass receives certificate to build rehabilitation hospital in Illinois EHC Encompass Health $85.86 / +0.18 (+0.21%) 01/15/21 UBS Encompass Health price target raised to $106 from $85 at UBS 12/18/20 Mizuho Encompass Health price target raised to $90 from $87 at Mizuho 11/30/20 Raymond James Encompass Health price target raised to $90 from $78 at Raymond James 11/23/20 Barclays Encompass Health upgraded to Overweight from Equal Weight at Barclays EHC Encompass Health $85.86 / +0.18 (+0.21%) 10/28/20 Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c 10/28/20 Encompass Health reports Q3 adjusted EPS 78c, consensus 78c 07/27/20 Encompass Health reports Q2 adjusted EPS 31c, consensus 42c 01/27/21 Encompass Health - EHC
Recommendations	Encompass Health price target raised to $106 from $85 at UBS » 08:28 01/15/21 01/15 08:28 01/15/21 08:28 EHC Encompass Health $82.47 / -0.87 (-1.04%) UBS analyst Whit Mayo… UBS analyst Whit Mayo raised the firm's price target on Encompass Health to $106 from $85 and keeps a Buy rating on the shares. Late last year, the company announced it would evaluate a range of potential strategic alternatives for its Home Health segment, the analyst tells investors in a research note. Mayo adds that he is "struck" by the "spread" implied at the stock's current levels relative to a potential transaction, noting that Encompass Health shares currently price in only a 78% probability of a deal. ShowHide Related Items >><< Company News Street Research Earnings Events EHC Encompass Health $82.47 / -0.87 (-1.04%) 01/06/21 Encompass Health, UnityPoint Health to build rehabilitation hospital in Illinois 12/09/20 Encompass Health exploring alternatives for Home Health and Hospice business 11/16/20 Jana Partners buys Encompass Health, exits Hillebrand in Q3 11/10/20 Encompass receives certificate to build rehabilitation hospital in Illinois EHC Encompass Health $82.47 / -0.87 (-1.04%) 12/18/20 Mizuho Encompass Health price target raised to $90 from $87 at Mizuho 11/30/20 Raymond James Encompass Health price target raised to $90 from $78 at Raymond James 11/23/20 Barclays Encompass Health upgraded to Overweight from Equal Weight at Barclays 11/02/20 Raymond James Encompass Health price target lowered to $78 from $86 at Raymond James EHC Encompass Health $82.47 / -0.87 (-1.04%) 10/28/20 Encompass Health sees Q4 adjusted EPS 79c-90c, consensus 93c 10/28/20 Encompass Health reports Q3 adjusted EPS 78c, consensus 78c 07/27/20 Encompass Health reports Q2 adjusted EPS 31c, consensus 42c 01/27/21 Encompass Health - EHC

On The Fly

News and insights, exclusive to thefly.com

13:18	Notable companies reporting before tomorrow's open»
13:17	Notable companies reporting after market close»
09:55	Fly Intel: Top five analyst initiations»
09:55	Fly Intel: Top five analyst downgrades»
09:55	Fly Intel: Top five analyst upgrades»

View all On The Fly Stories »

Upcoming
Events (10)

INFU	InfuSystem - INFU
ABNB ...	Media, Internet and Telecom Virtual Conference
RYN ...	Global Property Virtual Conference
AKAM ...	2nd Annual Software Investor Virtual Day
KLDO ...	3rd Annual Microbiome Medicines Virtual Summit
NTLA ...	Global Healthcare Virtual Conference 2021
MMSI	Merit Medical
JAMF	Jamf Holding
AZEK	Azek
JRVR	James River Group

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial